Back to Search
ARKADIUSZ DUDEK, M.D.
M.D.
Medical Oncology Physician
NPI: 1538197181IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
37108(MN)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
37108(MN)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
37108(MN)
Education
OTHER
Class of 1989
Research & Publications (20)
Sequential therapy with sorafenib and sunitinib in renal cell carcinoma.
PMID 19051290·Cancer·2009
8-other
Phase II trial of neoadjuvant therapy with carboplatin, gemcitabine plus thalidomide for stages IIB and III non-small cell lung cancer.
PMID 19633472·J Thorac Oncol·2009
3-trial
Phase I study of bortezomib and cetuximab in patients with solid tumours expressing epidermal growth factor receptor.
PMID 19401697·Br J Cancer·2009
3-trial
Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma.
PMID 18391603·Am J Clin Oncol·2008
3-trial
Phase 1/2 dose escalating study of twice-monthly pemetrexed and gemcitabine in patients with advanced cancer and non-small cell lung cancer.
PMID 18379358·J Thorac Oncol·2008
3-trial
Neoadjuvant chemotherapy with reduced-dose carboplatin and gemcitabine for non-small cell lung cancer in a patient with Fanconi anemia.
PMID 18379369·J Thorac Oncol·2008
5-case
Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.
PMID 17805485·Invest New Drugs·2008
7-preclinical
Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.
PMID 17653078·Br J Cancer·2007
7-preclinical
Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.
PMID 17921707·Am J Clin Oncol·2007
3-trial
Computational methods in developing quantitative structure-activity relationships (QSAR): a review.
PMID 16533155·Comb Chem High Throughput Screen·2006
8-other
Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
PMID 16290256·Lung Cancer·2006
4-observational
Hematopoietic stem cell transplant-related airflow obstruction.
PMID 16462178·Curr Opin Oncol·2006
6-review
Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival.
PMID 15945504·Cancer Invest·2005
4-observational
Molecular targets in the inhibition of angiogenesis.
PMID 12885272·Expert Opin Ther Targets·2003
6-review
Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.
PMID 14569562·Biol Blood Marrow Transplant·2003
8-other
Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis.
PMID 12586630·Blood·2003
8-other
Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.
PMID 19412810·Acta Oncol·2010
5-case
Ral overactivation in malignant peripheral nerve sheath tumors.
PMID 19414599·Mol Cell Biol·2009
7-preclinical
Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features of colonic and lung primary tumors.
PMID 19443356·Anticancer Res·2009
5-case
Novel insulin-like growth factor-methotrexate covalent conjugate inhibits tumor growth in vivo at lower dosage than methotrexate alone.
PMID 19446281·Transl Res·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1801 West Polk Street
Chicago, IL 60612 - Phone
- (312) 996-8705
Quick Facts
- NPI
- 1538197181
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile